• ADGRL3 (LPHN3) variants predict substance use disorder 

      Arcos-Burgos, Mauricio; Vélez, Jorge I.; Martinez, Ariel F.; Ribasés, Marta; Ramos-Quiroga, Josep A.; Sánchez-Mora, Cristina; Richarte, Vanesa; Roncero, Carlos; Cormand, Bru; Fernández-Castillo, Noelia; Casas, Miguel; Lopera, Francisco; Pineda, David A.; Palacio, Juan D.; Acosta-López, Johan E.; Cervantes-Henriquez, Martha L.; Sánchez-Rojas, Manuel G.; Puentes-Rozo, Pedro J.; Molina, Brooke S. G.; MTA Cooperative Group; Boden, Margaret T.; Wallis, Deeann; Lidbury, Brett; Newman, Saul; Easteal, Simon; Swanson, James; Patel, Hardip; Volkow, Nora; Acosta, Maria T.; Castellanos, Francisco X.; de Leon, Jose; Mastronardi, Claudio A.; Muenke, Maximilian (Nature Research, 2019-01)
      Genetic factors are strongly implicated in the susceptibility to develop externalizing syndromes such as attentiondeficit/ hyperactivity disorder (ADHD), oppositional defiant disorder, conduct disorder, and substance use ...
    • Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer’s Disease 

      Vélez, Jorge I.; Lopera, Francisco; Creagh, Penelope K.; Piñeros, Laura B.; Das, Debjani; Cervantes-Henríquez, Martha L.; Acosta-López, Johan E.; Isaza – Ruget, Mario A.; Espinosa, Lady G.; Easteal, Simon; Quintero, Gustavo A.; Tamar Silva, Claudia; Mastronardi, Claudio A.; Arcos-Burgos, Mauricio (SpringerLink, 2018-08)
      Background: The identification of novel genetic variants contributing to the widespread in the age of onset (AOO) of Alzheimer’s disease (AD) could aid in the prognosis and/or development of new therapeutic strategies ...